T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZYNE
2076
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $545K | ﹤0.01% |
40,192
-71,408
| -64% | -$824K |
|
2077
Banner Corp
BANR
$2.5B
| $542K | ﹤0.01% |
10,017
+119
| +1% | +$6.38K |
|
2078
Impinj
PI
$5.49B
| $541K | ﹤0.01% |
18,910
+8,540
| +82% | +$208K |
|
2079
Plug Power
PLUG
$3.2B
| $540K | ﹤0.01% |
239,993
-140,508
| -37% | -$349K |
|
2080
Alaunos Therapeutics
TCRT
$4.88M
| $540K | ﹤0.01% |
618
+5
| +0.8% | +$3.44K |
|
2081
Sturm, Ruger & Co
RGR
$600M
| $539K | ﹤0.01% |
9,888
+30
| +0.3% | +$1.59K |
|
2082
Range Resources
RRC
$9.39B
| $538K | ﹤0.01% |
77,113
-191,431
| -71% | -$1.66M |
|
|
PEGI
2083
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $536K | ﹤0.01% |
23,227
+334
| +1% | +$7.48K |
|
|
HSII
2084
DELISTED
Heidrick & Struggles
HSII
| $535K | ﹤0.01% |
17,860
| – | – |
|
2085
Pacific Biosciences
PACB
$345M
| $535K | ﹤0.01% |
88,487
+47,338
| +115% | +$332K |
|
2086
Cerus
CERS
$546M
| $531K | ﹤0.01% |
94,497
+377
| +0.4% | +$2.08K |
|
2087
Abercrombie & Fitch
ANF
$4.99B
| $529K | ﹤0.01% |
32,957
+138
| +0.4% | +$3.19K |
|
|
LABL
2088
DELISTED
Multi-Color Corp
LABL
| $529K | ﹤0.01% |
10,582
+42
| +0.4% | +$2.1K |
|
2089
Appian
APPN
$2.49B
| $528K | ﹤0.01% |
14,638
+5,138
| +54% | +$176K |
|
2090
LGI Homes
LGIH
$1.32B
| $520K | ﹤0.01% |
7,274
+74
| +1% | +$5.13K |
|
2091
1st Source
SRCE
$2.13B
| $520K | ﹤0.01% |
11,206
+38
| +0.3% | +$1.74K |
|
|
BIG
2092
DELISTED
Big Lots, Inc.
BIG
| $520K | ﹤0.01% |
18,163
+110
| +0.6% | +$3.67K |
|
2093
Valley National Bancorp
VLY
$8.25B
| $519K | ﹤0.01% |
48,184
+780
| +2% | +$7.99K |
|
2094
Tanger
SKT
$4.42B
| $516K | ﹤0.01% |
31,852
+130
| +0.4% | +$2.34K |
|
|
FLOW
2095
DELISTED
SPX FLOW, Inc.
FLOW
| $514K | ﹤0.01% |
12,285
+100
| +0.8% | +$3.7K |
|
|
FFIC
2096
DELISTED
Flushing Financial
FFIC
| $513K | ﹤0.01% |
23,118
+42
| +0.2% | +$926 |
|
2097
Modine Manufacturing
MOD
$10.6B
| $513K | ﹤0.01% |
35,815
+146
| +0.4% | +$2.09K |
|
2098
Unilever
UL
$133B
| $511K | ﹤0.01% |
7,325
-423
| -5% | -$28.7K |
|
|
DOOR
2099
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $511K | ﹤0.01% |
9,699
+59
| +0.6% | +$3.05K |
|
|
TWNK
2100
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $511K | ﹤0.01% |
35,395
-1,275,631
| -97% | -$17.1M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.